Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
161.20
+1.77 (1.11%)
At close: Nov 20, 2026, 4:00 PM EST
165.79
+4.59 (2.85%)
After-hours: Nov 20, 2026, 7:58 PM EST
Revolution Medicines Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bernstein | Bernstein | Hold Maintains $179 | Hold | Maintains | $179 | +11.04% | Nov 20, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $230 | Buy | Maintains | $230 | +42.68% | Nov 20, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $350 | Buy | Reiterates | $350 | +117.12% | Nov 17, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $272 → $247 | Buy | Maintains | $272 → $247 | +53.23% | Nov 13, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $274 | Buy | Maintains | $274 | +69.98% | Nov 13, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $246 → $289 | Buy | Maintains | $246 → $289 | +79.28% | Nov 10, 2026 |
Unknown Analyst Leerink Partners No rating | Leerink Partners | Buy Reiterates $288 → $311 | Buy | Reiterates | $288 → $311 | +92.93% | Nov 5, 2026 |
| TD Cowen | TD Cowen | Buy Reiterates $250 → $270 | Buy | Reiterates | $250 → $270 | +67.49% | Nov 5, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.